Chronic diseases: including MAFLD, sarcopenia, diabetes and its related complications, cardiovascular and cerebrovascular diseases, osteoporosis, etc.
Conditions
Interventions
Trial group:None
Sponsors
he First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: (1) Data with complete exposure variables, outcome variables, and control variables; (2) Age >=18 years; (3) Complete and retrievable clinical records; (4) Informed consent for this study.
Exclusion criteria
Exclusion criteria: (1) Secondary diabetes (e.g., Cushing's syndrome, post-pancreatectomy); (2) Concurrent malignancy, severe hepatic or renal insufficiency, or autoimmune disease; (3) Recent use of glucocorticoids or immunosuppressants; (4) Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete blood count;high-sensitivity C-reactive protein;Fasting blood glucose;2-hour postprandial blood glucose;glycated hemoglobin (HbA1c);triglycerides;receptor operating characteristic, ROC;area under the curve, AUC;sensitivity;specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| liver function;kidney function;height;weight;waist circumference;Appendicular Skeletal Muscle Mass;coagulation;urinary microalbumin; | — |
Countries
China
Contacts
Public ContactQingfeng Cheng
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed